Preclinical Research
A rat wound study of thymosin beta-4 is still a rat wound study
Malinda and colleagues reported faster re-epithelialization in a full-thickness rat model. The peptide in the paper is thymosin beta-4, and the subjects were rats.
This is a preclinical paper. Malinda and colleagues, Journal of Investigative Dermatology, 1999, tested thymosin beta-4 in a full-thickness wound model in rats, given on the wound or by intraperitoneal injection, against saline. They also tested keratinocyte migration in a chamber assay. No patient is in the methods.
The numbers, still attached to the rat
The abstract reports re-epithelialization 42 percent above saline controls at 4 days and as much as 61 percent at 7 days, and wound contraction at least 11 percent greater by day 7. Treated wounds showed more collagen and more angiogenesis on histology. In the migration assay, as little as 10 picograms increased keratinocyte movement two- to threefold over medium alone. Those quantities are assay and model quantities.
Not a catalog fragment
Thymosin beta-4 in this experiment is not a research-supply fragment sold under another code, and a percentage gain in rat skin is not a human healing protocol. The useful reading is the one that keeps the species in the sentence. PMID 10469335.